BioStem Technologies, Inc.

NASDAQ:BSEM

Biotechnology

Healthcare
$3.07 -6.54%

-$0.21 today

Market cap
$52.14M
Beta
0.26
P/E (TTM)
-1.8
EPS (TTM)
-$1.63
52W Low $2.25High $8.40

Volume 0.09M

Average 0.07M

BSEM Net Debt

Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.

BioStem Technologies, Inc.NASDAQ: BSEM

Net Debt · Q2 FY2026 · quarter ended Jun 2026

Net debt remains negative

Q2 FY2026 net debt was -$5.74M, compared with -$27.26M a year earlier.

Context

  • Net debt amounted to 11.8% of total assets at the end of Q2 FY2026, down 12.4 pp from a year earlier.
  • Net debt increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether net debt keeps rising in the next quarterly balance sheet after a +78.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$5.74M+44.9% QoQ
Last fiscal yearDec 2025
-$26.22M-43.0% YoY
Year agoJun 2025
-$27.26M+78.9% since
Net Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+78.9%——
1 year-43.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Debt history

USD · from the balance sheet

Latest · FY2025
(26.22M) USD
Year-over-year change
-43.0%

Net Debt vs competitors

How BSEM compares with its peers on the latest reported figures

No competitor Net Debt figures are available to compare.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents340.33K772.14K239.41K22.83M29.55M
Short-term Investments00000
Net Receivables300.14K37.21K11.37M106.23M9.87M
Inventory260.05K395.23K658.68K1.82M2.88M
Other Current Assets00329.24K2.87M2.1M
Total Current Assets938.6K1.49M12.6M133.76M44.4M
Property, Plant & Equipment (Net)1.28M1.37M1.37M1.97M5.26M
Goodwill244.64K244.64K244.64K244.64K244.64K
Intangible Assets210.05K362.57K347.6K224.14K119.77K
Long-term Investments00(347.6K)00
Tax Assets0110.95K04.35M0
Other Non-current Assets0(110.95K)347.6K00
Total Non-current Assets1.73M1.98M1.96M6.79M5.62M
Total Assets2.67M3.47M14.56M140.55M50.03M
Account Payables647.26K48.64K1.39M5.29M4.44M
Short-term Debt3M4.04M4.45M4.06M3.23M
Tax Payables00000
Deferred Revenue2.47M8.06K8.73K00
Other Current Liabilities(903.79K)150.54K245.02K86.8M977.27K
Total Current Liabilities6.54M6.33M15.62M99.17M10.78M
Long-term Debt1.8M1.03M265.64K150K0
Deferred Tax Liabilities0110.95K0174.27K0
Deferred Revenue (Non-current)0(110.95K)000
Other Non-current Liabilities120.21K0000
Total Non-current Liabilities1.92M1.09M283.78K504.5K105.26K
Total Liabilities8.47M7.42M15.9M99.67M10.89M
Common Stock9.74K12.16K16.22K16.66K16.83K
Retained Earnings(29.95M)(37.02M)(45.62M)(13.74M)(21.17M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest165.29K126.44K000
Total Equity(5.79M)(3.95M)(1.34M)40.88M39.14M
Total Debt4.83M5.21M4.77M4.5M3.33M
Net Debt4.49M4.32M4.53M(18.33M)(26.22M)

BioStem Technologies, Inc.

NASDAQ:BSEM

Intrinsic Alpha fair value

Locked

Current Price

$3.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.